From: The CLDN5 gene at the blood-brain barrier in health and disease
Amino acid positions counted by human CLDN-5 sequence | Key features | Ref |
---|---|---|
W30 and G48/L49/W50 and R81 | The canonical CLDN signature to create its first ECL structure. | [138] |
S69/Q78/R81 and E159 | Cis-interaction by a stable hydrogen bond between S69 and E159. | |
F139 | It interacts with W30 and stabilizes the secondary structure. Only CLDN-5 has F at this position among classic CLDNs. | [146] |
L73 and F147/Y148 | Cis-interaction. F147/Y148 creates a hydrophobic pocket. | [140] |
H61 to K65 | The interface of cis-interaction for dimerization. | [229] |
P135 | It makes TJ strands more rigid by reducing the conformational flexibility of cis-/trans-interaction | [141] |
F35, N39 to Q44 | The interface of trans-interaction. The interaction of these hydrophobic residues may create a barrier against water molecules. | |
F147 to Q156 | The interface of trans-interaction. F147A, Y148A or Q156E mutant does not form trans-interaction. | |
K65 and D68 | The salt bridge (or hydrogen bond) between these positions limits the ion permeability. | |
Q57 | A polar but uncharged amino acid like Q and H is necessary for some CLDNs to form cis-interaction and to localize at the TJs. | |
Q57 and H61 and Q63 | Putative ion gate for extracellular ions is located here in channel-forming CLDNs. Barrier forming CLDNs have Q57 and Q61 (only CLDN-5 has H here) and Q63 and make multiple hydrogen bonds to close this gate. | [148] |